Stocks
Funds
Screener
Sectors
Watchlists

Latest BRAIDWELL LP Stock Portfolio

BRAIDWELL LP Performance:
2025 Q3: 6.74%YTD: -5.27%2024: -10.2%

Performance for 2025 Q3 is 6.74%, and YTD is -5.27%, and 2024 is -10.2%.

About BRAIDWELL LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, BRAIDWELL LP reported an equity portfolio of $3.4 Billions as of 30 Sep, 2025.

The top stock holdings of BRAIDWELL LP are , XENE, . The fund has invested 6.6% of it's portfolio in CARIS LIFE SCIENCES INC and 4.3% of portfolio in XENON PHARMACEUTICALS INC.

The fund managers got completely rid off GUARDANT HEALTH INC (GH), APELLIS PHARMACEUTICALS INC (APLS) and MADRIGAL PHARMACEUTICALS INC (MDGL) stocks. They significantly reduced their stock positions in ADAPTIVE BIOTECHNOLOGIES COR (ADPT), SIONNA THERAPEUTICS INC and HARROW INC (HROW). BRAIDWELL LP opened new stock positions in SOLENO THERAPEUTICS INC (SLNO), ACADIA PHARMACEUTICALS INC (ACAD) and HINGE HEALTH INC. The fund showed a lot of confidence in some stocks as they added substantially to REPLIMUNE GROUP INC (REPL), GLOBUS MED INC (GMED) and INSPIRE MED SYS INC (INSP).

BRAIDWELL LP Annual Return Estimates Vs S&P 500

Our best estimate is that BRAIDWELL LP made a return of 6.74% in the last quarter. In trailing 12 months, it's portfolio return was -13.42%.

New Buys

Ticker$ Bought
soleno therapeutics inc86,662,500
acadia pharmaceuticals inc50,760,500
hinge health inc44,686,200
cvs health corp33,066,100
dianthus therapeutics inc32,859,500
caredx inc31,737,600
biomarin pharmaceutical inc28,596,500
tenet healthcare corp24,710,000

New stocks bought by BRAIDWELL LP

Additions to existing portfolio by BRAIDWELL LP

Reductions

Ticker% Reduced
adaptive biotechnologies cor-80.95
immunocore hldgs plc-74.55
sionna therapeutics inc-70.97
argenx se-60.88
harrow inc-60.75
alphatec hldgs inc-58.33
viking therapeutics inc-47.17
kiniksa pharmaceuticals intl-41.67

BRAIDWELL LP reduced stake in above stock

Sold off

Ticker$ Sold
alphatec hldgs inc-5,769,180
apellis pharmaceuticals inc-19,405,100
celcuity inc-11,805,500
guardant health inc-43,599,100
crescent biopharma inc.-4,220,680
madrigal pharmaceuticals inc-18,394,800
unitedhealth group inc-15,411,300

BRAIDWELL LP got rid off the above stocks

Sector Distribution

BRAIDWELL LP has about 70.8% of it's holdings in Healthcare sector.

Sector%
Healthcare70.8
Others29.2

Market Cap. Distribution

BRAIDWELL LP has about 19.4% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP33.7
UNALLOCATED29.2
LARGE-CAP17.2
SMALL-CAP17.2
MEGA-CAP2.2

Stocks belong to which Index?

About 42% of the stocks held by BRAIDWELL LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others58
RUSSELL 200031.5
S&P 50010.5
Top 5 Winners (%)%
zura bio ltd
312.4 %
oruka therapeutics inc
68.2 %
cg oncology inc
54.9 %
sionna therapeutics inc
44.8 %
SRZN
surrozen inc
44.1 %
Top 5 Winners ($)$
cg oncology inc
46.9 M
XENE
xenon pharmaceuticals inc
31.9 M
caris life sciences inc
25.8 M
argenx se
25.2 M
KRYS
krystal biotech inc
24.4 M
Top 5 Losers (%)%
REPL
replimune group inc
-41.3 %
LUNG
pulmonx corp
-37.5 %
INSP
inspire med sys inc
-37.3 %
ALGN
align technology inc
-30.9 %
GKOS
glaukos corp
-19.1 %
Top 5 Losers ($)$
INSP
inspire med sys inc
-39.1 M
ALGN
align technology inc
-29.1 M
GKOS
glaukos corp
-15.0 M
ISRG
intuitive surgical inc
-10.6 M
REPL
replimune group inc
-8.1 M

BRAIDWELL LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of BRAIDWELL LP

BRAIDWELL LP has 64 stocks in it's portfolio. About 32.7% of the portfolio is in top 10 stocks. INSP proved to be the most loss making stock for the portfolio. was the most profitable stock for BRAIDWELL LP last quarter.

Last Reported on: 14 Nov, 2025
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions